The company behind the supersized theatrical experiences issued its mid-quarter box office update yesterday.
The gross box office receipts collected during this quarter on IMAX screenings -- through May 13 -- was roughly $96.5 million, nearly triple the $32.6 million in sales during the same period last year.
Between the bar-raising success of Disney's
However, the real meat in the metrics rests in the geographical breakdown. Just $40.8 million of the $96.5 million in ticket sales realized over the past six weeks originated in North American theaters. International ticketing is the big winner at $55.7 million.
During last year's mid-quarter update, domestic sales were nearly double the company's international business.
Now, it's important for investors to know what these numbers mean. They can't just pull up the $71 million that analysts are targeting in revenue and wrongly assume that box office receipts alone will barrel past that target.
IMAX records just a piece of the $96.5 million in ticket sales. Movie studios and exhibitors take the biggest chunks, though IMAX takes a bigger bite than usual in joint-venture screens. The performance is still encouraging. Strong box office receipts result in movie studios trying harder to secure IMAX distribution and theater owners embracing the premium platform.
IMAX wins in more ways than one.
I've been a believer in IMAX for years. It's been a market beater both times that I have recommended IMAX as an investment to Rule Breakers newsletter subscribers. As part of the CAPScall initiative for accountability, I've also had a bullish IMAX call on Motley Fool CAPS for some time.
If you're ready for a different kind of feature presentation, ask yourself if you know the two words that are scaring the pants off Steve Ballmer. It's a free report, but like a hot theatrical release it won't be showing forever, so check it out now.